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Abstract
The	pathology	of	spinocerebellar	ataxia	type	3,	also	known	as	Machado‐Joseph	dis-
ease, is triggered by aggregation of toxic ataxin-3 (ATXN3) variants containing ex-
panded polyglutamine repeats. The physiological role of this deubiquitylase, however, 
remains largely unclear. Our recent work showed that ATX-3, the nematode ortho-
logue	of	ATXN3,	together	with	the	ubiquitin‐directed	segregase	CDC‐48,	regulates	
longevity in Caenorhabditis elegans. Here, we demonstrate that the long-lived cdc‐48.1; 
atx‐3 double mutant displays reduced viability under prolonged starvation conditions 
that can be attributed to the loss of catalytically active ATX-3. Reducing the levels 
of the autophagy protein BEC-1 sensitized worms to the effect of ATX-3 deficiency, 
suggesting a role of ATX-3 in autophagy. In support of this conclusion, the depletion 
of ATXN3 in human cells caused a reduction in autophagosomal degradation of pro-
teins.	Surprisingly,	 reduced	degradation	 in	ATXN3‐depleted	cells	coincided	with	an	
increase in the number of autophagosomes while levels of lipidated LC3 remained un-
affected.	We	identified	two	conserved	LIR	domains	in	the	catalytic	Josephin	domain	
of ATXN3 that directly interacted with the autophagy adaptors LC3C and GABARAP 
in	vitro.	While	ATXN3	localized	to	early	autophagosomes,	it	was	not	subject	to	lysoso-
mal degradation, suggesting a transient regulatory interaction early in the autophagic 
pathway.	We	propose	that	the	deubiquitylase	ATX‐3/ATXN3	stimulates	autophagic	
degradation by preventing superfluous initiation of autophagosomes, thereby pro-
moting an efficient autophagic flux important to survive starvation.
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1  | INTRODUC TION
Ataxin-3 (ATXN3), which is the founding member of the fam-
ily	 of	 Josephin	 domain‐containing	 deubiquitylases	 (DUBs),	 plays	
a critical role in the maintenance of protein homeostasis and 
stress	 resistance	 (Burnett	&	Pittman,	2005;	Durcan	et	 al.,	 2011;	
Scaglione	 et	 al.,	 2011;	Wang,	 Li,	 &	 Ye,	 2006;	 Zhong	 &	 Pittman,	
2006).	Abnormal	expansion	of	a	stretch	of	glutamine	residues	 in	
the C-terminus of ATXN3 is causative for spinocerebellar ataxia 
type	3	(SCA3),	also	known	as	Machado–Joseph	disease,	the	most	
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common	hereditary	type	of	ataxia	(Kawaguchi	et	al.,	1994).	While	
mutant ATXN3 causes neuronal demise through a predomi-
nant, toxic gain-of-function mechanism typically associated with 
polyglutamine (polyQ) disorders, wild-type ATXN3 has neuro-
protective properties and can reduce the toxicity caused by poly-
glutamine proteins in cellular and Drosophila models (Tsou et al., 
2015;	Warrick	et	al.,	2005).	Hence,	a	loss	of	its	protective	function	
may contribute to the disease, consistent with a general role of 
ATXN3 in maintaining protein homeostasis.
Interestingly, simultaneous inactivation of ATX-3, and the ubiq-
uitin‐selective	segregase	CDC‐48.1	in	the	nematode	Caenorhabditis 
elegans	 (Olszewski,	Williams,	Dong,	&	Martin,	2019),	 results	 in	ex-
tended lifespan (Kuhlbrodt et al., 2011). This synergistic effect on 
the longevity of cdc‐48.1; atx‐3 double mutants depends on the insu-
lin/insulin‐like	growth	factor‐1	signaling	(IIS)	pathway	(Kuhlbrodt	et	
al., 2011). Aging is typically accompanied by a gradual decline in the 
functionality of autophagy, and conversely, genetic or dietary stimu-
lation of autophagy promotes longevity in various model organisms 
(Leidal,	Levine,	&	Debnath,	2018).	Hence,	there	appears	to	be	a	posi-
tive correlation between lifespan and the functionality of autophagy, 
which	is	also	triggered	by	IIS	(Melendez	et	al.,	2003).
Another emerging theme is the involvement of proteins linked 
to age-related neurodegenerative disorders in the autophagic deg-
radation	 of	 aberrant	 proteins	 and	 organelles	 (Menzies,	 Fleming,	 &	
Rubinsztein, 2015). Dysfunction of neurodegeneration-associated 
proteins involved in autophagy may lead to impaired autophagy, which 
has been proposed to contribute to the pathophysiology in various 
neurodegenerative	disorders	(Ashkenazi	et	al.,	2017;	Ju	et	al.,	2009;	
Martinez-Vicente et al., 2010; Rui et al., 2015; Tresse et al., 2010). 
Thus, ATX-3/ATXN3 is linked to both longevity and neurodegenera-
tive disorders, which are associated with increased and impaired au-
tophagy, respectively.
Autophagy can be triggered by a variety of stressors, such as 
the presence of cytotoxic protein aggregates, to ensure cell survival, 
while also regulating nutrient recycling during periods of nutrient 
deprivation. The initiation, formation, and elongation of the auto-
phagosomal membrane is regulated by phosphatidylethanolamine 
(PE) conjugation and autophagosomal anchoring of six highly re-
lated	 ubiquitin‐like	modifiers	 belonging	 to	 the	 Atg8	 family:	 LC3A,	
LC3B, LC3C, GABARAP, GABARAPL1, and GABARAPL2. LC3s and 
GABARAPs play critical roles in facilitating the recruitment of cargo 
receptors and other autophagy proteins to autophagosomes by di-
rectly interacting with these proteins through conserved LC3-inter-
acting	 regions	 (LIRs)	 (Johansen	&	Lamark,	2011).	After	 fusion	with	
lysosomes, the fraction of LC3/GABARAP localized on the luminal 
side of autophagic vesicles is degraded in the lysosomes together 
with cargo receptors and substrates, while LC3/GABARAP present 
on	the	cytosolic	face	is	released	by	Atg4	protease	(Abreu	et	al.,	2017).
Despite the well-established involvement of ubiquitin ligases 
in autophagy, the role of DUBs in this process has only recently 
gained	 interest	 (Clague	&	Urbe,	2017).	Beclin‐1	has	been	 shown	
to	 be	 a	 prominent	 substrate	 of	 various	DUBs,	 including	 USP10,	
USP13	(Liu	et	al.,	2011),	USP9X	(Elgendy	et	al.,	2014),	and	ATXN3	
(Ashkenazi	 et	 al.,	 2017).	 As	 a	 core	 component	 of	 the	 class	 III	
PI3‐kinase/Vps34	 complex,	 beclin‐1	 supports	 the	 induction	 of	
autophagy	 by	 stimulation	 of	 Vps34‐dependent	 generation	 of	
phosphatidylinositol‐3‐phosphate.	 Stabilization	 of	 beclin‐1	 by	
ATXN3 has been proposed to promote lipidation of LC3 and auto-
phagy	(Ashkenazi	et	al.,	2017).
Here, we show that the long-lived cdc‐48.1; atx‐3 double mutant 
displays increased sensitivity to nutrient starvation and impaired 
ability to clear aggregation-prone proteins, two phenotypes that are 
indicative for defective autophagy. In agreement with a new phys-
iological role of ATXN3 in autophagy, we show that ATXN3 is an 
LC3C/GABARAP-interacting DUB that regulates the formation of 
autophagosomes independent from its stabilizing effect on beclin-1 
(Ashkenazi	et	al.,	2017).	Our	study	implicates	a	conserved	regulatory	
role for ATX-3/ATXN3 in autophagy and shows that increased lifes-
pan can come at the expense of a reduced ability to maintain organis-
mal protein homeostasis under stress conditions, such as starvation.
2  | RESULTS
2.1 | Autophagy is impaired in ATX‐3‐deficient 
worms
Given the correlation between lifespan and autophagy, we ex-
plored the functional status of autophagy in long-lived cdc‐48.1; 
F I G U R E  1   Autophagy is impaired in atx‐3	deletion	worms.	(a)	Survival	rate	upon	refeeding	of	starved	L1	larvae	of	the	long‐lived	strain	
cdc‐48.1(tm544); atx‐3(gk193) or the single-deletion strains atx‐3(gk193) and cdc‐48.1(tm544)	compared	with	wild‐type	worms.	(b)	Starved	
L1 larvae of the atx‐3 deletion strains atx‐3(tm1689) and atx‐3(gk193) show decreased survival rate upon refeeding compared with wild-type 
worms. (c) The decreased survival of the atx‐3(gk193) mutant strain can be rescued by introduction of GFP-tagged wild-type ATX-3 protein 
but	not	the	catalytic	inactive	mutant	C20S.	(d)	Reduction	in	bec‐1 levels by RNAi further decreases the survival of atx‐3(gk193) mutant 
worms	upon	starvation.	(e)	Western	blot	analysis	of	autophagy	protein	LGG‐1	in	total	worm	lysates	of	day	1	adult	well‐fed	worms	or	worms	
starved	for	9	hr.	Worms	were	treated	with	the	lysosomal	inhibitor	chloroquine	at	the	indicated	concentration	from	L4	stage	(performed	in	
duplicates for treatment with 5 mM chloroquine). Immunoblotting was performed using anti-GFP and anti-tubulin antibodies. (f) Total worm 
lysates	of	mutant	and	wild‐type	worms	expressing	Q40‐YFP	aggregation‐prone	protein	in	body‐wall	muscle	cells	have	been	subjected	to	
Western	blot	analysis.	The	Western	blot	shows	the	amounts	of	Q40::YFP	and	ATX‐3	protein	in	the	PBS‐soluble	(S)	and	PBS‐insoluble	(pellet,	
P;	only	dissolved	in	SDS‐containing	buffer)	fraction	of	total	worm	lysates	in	WT,	atx‐3(gk193), and cdc‐48.1(tm1544); atx‐3(gk193) mutants. 
Western	blot	analysis	was	done	using	anti‐GFP	and	anti‐ATX‐3	antibodies.	(g)	Quantification	of	relative	band	intensities	of	Q40‐YFP	in	
soluble and pellet fraction was done. Data are presented as mean value and SD derived from two independent experiments. (h) Relative 
motility	of	indicated	strains	expressing	aggregation‐prone	Q40‐YFP	protein	in	body‐wall	muscle	cells	(Student's	t test, unpaired, two-tailed, 
n	≥	20,	*p	≤	.05,	***p	≤	.001)
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atx‐3 double mutant worms. To this end, we examined the survival 
of starved L1 larvae, a metabolic challenge that strongly depends 
on	 functional	 autophagy	 (Kovacs	 &	 Zhang,	 2010).	 When	 worms	
hatch in the absence of food, larvae arrest at the L1 diapause and 
can survive for several weeks, from which they recover and resume 
growth	upon	refeeding.	We	found	that	the	cdc‐48.1; atx‐3 deletion 
mutant had a significantly decreased recovery rate and reduced vi-
ability in comparison with wild-type worms, indicative of a defect 
in	 the	autophagy–lysosome	pathway	 (Figure	1a,	Table	S1).	ATXN3	
and	p97	(also	known	as	valosin‐containing	protein	(VCP)),	which	are	
the	 human	 orthologues	 of	 ATX‐3	 and	CDC‐48,	 respectively,	 have	
both	been	implicated	in	autophagy	(Ashkenazi	et	al.,	2017;	Ju	et	al.,	
2009; Tresse et al., 2010). To clarify to what extent the increased 
sensitivity	could	be	attributed	to	ATX‐3	or	CDC‐48,	we	next	evalu-
ated the survival of atx‐3 or cdc‐48.1	single‐deletion	strains.	While	
the	deletion	of	CDC‐48	did	not	increase	the	sensitivity	of	larvae	to	
starvation	(Figure	1a,	Table	S1),	the	two	independent	atx‐3 deletion 
alleles tm1689 and gk193 phenocopied the starvation sensitivity of 
the cdc‐48.1; atx‐3	double	mutant	(Figure	1b,	Table	S2).	Importantly,	
the decreased survival of ATX-3-deficient worms upon starvation 
could be rescued by reintroduction of GFP-tagged wild-type ATX-3 
but not by the catalytically inactive ATX-3C20S mutant (Figure 1c, 
Table	S3).
While	 autophagy	 promotes	 the	 survival	 of	 L1	 larvae	 during	
starvation, its excessive activation or misregulation is not bene-
ficial but rather increases the mortality of starving worms (Kang, 
You,	 &	 Avery,	 2007).	 To	 analyze	 whether	 reduced	 or	 increased	
autophagy is accountable for the decreased survival of atx‐3 de-
letion worms, we curtailed autophagy through silencing of bec‐1, 
the	worm	orthologue	 of	 beclin‐1.	We	 found	 that	 the	 partial	 de-
pletion of bec‐1 did not rescue but further reduced the survival of 
the mutant worms, implying that the deletion of atx‐3 results in 
a	reduced	activity	of	autophagy	 (Figure	1d,	Table	S4).	Moreover,	
it suggests that it reduces autophagy activity independent of the 
BEC-1 complex, which was further supported by the observation 
that the levels of lipidated GFP-LGG-1, the nematode orthologue 
of LC3/GABARAP, remained unaffected upon deletion of ATX-3 
(Figure	 1e).	 Similarly,	 we	 observed	 that	 the	 partial	 depletion	 of	
unc‐51, the nematode orthologue of ULK1, which is the upstream 
Ser/Thr	protein	kinase	involved	in	the	activation	of	autophagy	in	
C. elegans, further aggravated the mortality of atx‐3 mutant worms 
(Figure	S1A,	Table	S5).
Another process that strongly depends on functional autoph-
agy and that is of direct relevance for polyQ diseases is the clear-
ance	of	 aggregation‐prone	proteins	 (Ravikumar	et	 al.,	 2004).	Both	
wild-type and ATX-3-deficient worms developed visible inclusions 
upon muscle-specific expression of an aggregation-prone polyQ 
repeat	 (Morley,	Brignull,	Weyers,	&	Morimoto,	2002)	 (Figure	S1B).	
Biochemical	 analysis	 showed	 an	 increase	 in	 SDS‐insoluble	 polyQ‐
YFP	aggregates	in	the	atx‐3-deficient strain that was comparable to 
the cdc‐48.1; atx‐3 double mutant, consistent with reduced clearance 
of protein aggregates (Figure 1f,g). PolyQ-based aggregation in the 
muscle triggered reduced motility of atx‐3 and cdc‐48.1; atx‐3 mu-
tant worms compared with wild-type worms (Figure 1h). Combined, 
these data suggest a stimulatory role of ATX-3 in autophagy in a mul-
ticellular organism relevant for the cellular stress response to starva-
tion and protein aggregation.
2.2 | ATXN3 depletion impairs autophagic 
degradation of long‐lived proteins and increases the 
number of autophagosomes
To explore whether human ATXN3 is involved in autophagy, we 
analyzed the autophagic flux directly by determining the fraction of 
long-lived intracellular proteins that were either degraded by basal 
or starvation-induced autophagy in control or ATXN3-depleted 
cells.	We	used	two	different	ATXN3‐specific	siRNAs	that	both	effi-
ciently depleted ATXN3 (Figure 2a). Proteins were metabolically la-
beled,	followed	by	a	16‐hr	chase	to	allow	degradation	of	short‐lived	
proteins.	Degradation	of	long‐lived	proteins	during	a	4‐hr	starvation	
F I G U R E  2   ATXN3 depletion increases the number of autophagosomes and impairs degradation of long-lived proteins. (a) Knockdown 
efficiency	of	two	different	siRNAs	targeting	ATXN3	(ATXN3si	#1,	ATXN3si	#2)	in	HOS	GFP‐LC3	cells.	(b)	Long‐lived	protein	degradation	
assay	in	U2OS	cells	depleted	of	ATXN3	and	treated	as	indicated.	Percentage	of	long‐lived	protein	degradation	was	quantified.	Data	are	
presented as mean ± SD	of	three	independent	experiments,	each	performed	in	technical	duplicates.	*p	≤	.05,	**p	≤	.01,	***p	≤	.001	(one‐
way ANOVA). (c) Percentage of long-lived protein degradation by autophagy was quantified as the bafilomycin A1-sensitive fraction of 
degradation	during	starvation	in	(b);	*p	≤	.05,	**p	≤	.01,	***p	≤	.001	(one‐way	ANOVA).	(d)	Representative	micrographs	of	HOS	GFP‐LC3	
cells depleted of ATXN3 using two different siRNAs (ATXN3si #1, ATXN3si #2). Cells were treated as indicated and imaged live using an 
automated	widefield	microscope.	Scale	bar:	20	μm.	(e)	Quantification	of	GFP‐LC3	puncta	per	cell	upon	ATXN3	depletion	in	HOS	GFP‐LC3	
cells.	Data	are	presented	as	box	plot	with	median	and	5–95	percentile	of	at	least	two	independent	experiments,	n	≥	360,	*p	≤	.05,	**p	≤	.01,	
***p	≤	.001	(Kruskal–Wallis	test).	(f)	Representative	micrographs	of	endogenous	LC3B	in	wild‐type	or	ATXN3	knockout	(KO)	mouse	
embryonic	fibroblasts	(MEFs)	treated	as	indicated	for	4	hr.	Scale	bar:	20	μm	(g)	Western	blot	analysis	of	autophagy	proteins	in	HOS	GFP‐LC3	
upon	siRNA‐mediated	depletion	of	ATXN3.	Cells	were	treated	as	indicated	for	4	hr	and	analyzed	by	immunoblotting	using	the	indicated	
antibodies (s.e.: short exposure; l.e.: long exposure). (h) Quantification of GFP-LC3 puncta per cell upon ATXN3 depletion using ATXN3si #2 
and	transient	overexpression	of	mCherry‐C1	(mCh.),	mCherry‐ATXN3	WT	(WT),	or	mCherry‐ATXN3	C14A	(C14A)	in	HOS	GFP‐LC3	cells.	
Cells	were	starved	for	4	hr	in	the	presence	of	100	nM	bafilomycin	A1.	Data	are	presented	as	box	plot	with	median	and	5–95	percentile	of	
four independent experiments, n	≥	700,	*p	≤	.05,	**p	≤	.01,	***p	≤	.001	(Kruskal–Wallis	test).	(i)	Representative	micrographs	of	HOS	GFP‐LC3	
cells	depleted	of	ATXN3	using	ATXN3si	#2	and	transfected	with	mCherry‐C1	(mCh.),	mCherry‐ATXN3	WT	(WT),	or	mCherry‐ATXN3	C14A	
(C14A).	Cells	were	imaged	live	using	an	automated	widefield	microscope.	Intensities	in	micrographs	showing	mCherry	signal	of	WT	and	
C14A	samples	were	rescaled.	Scale	bar:	20	μm
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period was monitored by quantification of free radiolabeled amino 
acids	 (Klionsky	et	al.,	2016).	This	analysis	revealed	that	the	deple-
tion of ATXN3 with two independent siRNAs caused a significant 
reduction in degradation of long-lived proteins in starved cells 
(Figure	2b),	which	corresponded	to	an	estimated	20%–50%	reduc-
tion in autophagic flux based on the difference in degradation of 
long-lived proteins in control and ATXN3-depleted cells during star-
vation compared with starvation in the presence of bafilomycin A1 
(Figure 2c).
GFP-LC3 shows diffuse fluorescence under normal conditions 
but localizes to autophagosomes when autophagy is induced by nu-
trient starvation, which can be quantified by fluorescence micros-
copy	 analysis	 of	 the	 number	 of	 fluorescent	 puncta.	 Surprisingly,	
the depletion of ATXN3 with either siRNA resulted in a signifi-
cant increase in GFP-LC3 puncta when lysosomal degradation 
was blocked by bafilomycin A1 treatment under basal and nutri-
ent-starved conditions (Figure 2d,e). This increase suggests that 
more autophagic structures were formed in ATXN3-depleted cells 
during the treatment. To validate this finding, we stained similarly 
treated wild-type and ATXN3 knockout murine embryonic fibro-
blasts	(Schmitt	et	al.,	2007;	Weishaupl	et	al.,	2019)	for	endogenous	
LC3, which confirmed elevated levels of both basal and starvation-
induced LC3 puncta in ATXN3 knockout cells (Figure 2f, Figure 
S2A,B).	 No	 increase	 in	 LC3	 foci	was	 observed	when	ATXN3‐de-
pleted cells were starved in the presence of the phosphatidylinosi-
tol-3-kinase (PI3K) inhibitor wortmannin, indicating that ATXN3 
acts	 in	 the	 canonical	 autophagy–lysosome	 pathway	 downstream	
of	PI3K	 (Figure	2e,	Figure	S2C).	The	 increase	 in	GFP‐LC3	puncta	
in ATXN3-depleted cells was not accompanied by a detectable 
increase in the levels of lipidated GFP-LC3 (Figure 2g) or endog-
enous	 lipidated	 LC3/GABARAP	 (Figure	 2g,	 Figure	 S2D,E).	 This	
observation suggests that the accumulation of GFP-LC3 puncta in 
ATXN3-depleted cells does not reflect a change in the levels of au-
tophagosome-associated LC3.
Despite its ability to increase the number of autophagosomes, 
the depletion of ATXN3 did not increase the autophagic flux as mea-
sured	using	double‐tagged	mRFP‐GFP‐LC3	 (Figure	S3A).	We,	how-
ever, consistently detected increased mRFP and GFP intensities in 
ATXN3-depleted samples during starvation, both in the presence or 
in the absence of bafilomycin A1 treatment compared with controls, 
confirming the increase in autophagosomes detected by microscopy 
(Figure	 S3B‐E).	 Notably,	 the	 levels	 of	 beclin‐1	were	 not	 altered	 in	
ATXN3‐depleted	GFP‐LC3	HOS	cells	(Figure	2g),	HeLa	cells	(Figure	
S2D),	or	U2OS	cells	(Figure	S2E),	excluding	that	effects	on	autoph-
agy were caused by enhanced proteasomal degradation of beclin-1, 
which has recently been identified as an ATXN3 substrate (Ashkenazi 
et	al.,	2017).
The increase in GFP-LC3 puncta upon ATXN3 depletion was 
rescued by transient overexpression of wild-type but not catalyti-
cally inactive mCherry-ATXN3, confirming that the observed effect 
is	 specific	 for	ATXN3	 (Figure	2h,i,	 Figure	S4).	Furthermore,	 in	 line	
with our observations in C. elegans, these data suggest that ATXN3 
requires its DUB activity to support autophagy.
2.3 | ATXN3 acts upstream of p97/VCP
The	ATXN3	interactor	p97/VCP,	the	human	orthologue	of	CDC‐48,	
has been linked to the maturation of autophagosomes by a yet-to-
be	determined	mechanism	 (Ju	et	 al.,	 2009;	Tresse	et	 al.,	 2010).	 In	
order	to	assess	whether	the	effect	of	ATXN3	is	epistatic	with	p97/
VCP	depletion,	we	either	depleted	ATXN3,	p97/VCP,	or	both	simul-
taneously, and analyzed the accumulation of LC3 puncta. Despite 
the	 fact	 that	 both	 p97/VCP	 and	 ATXN3	 depletion	 had	 a	 striking	
effect on the localization of GFP-LC3 foci, the distribution pattern 
was rather different with a more perinuclear localization of LC3 in 
p97/VCP‐depleted	 cells	 (Figure	 3a,b).	 The	 number	 of	 LC3	 puncta	
was	 not	 affected	 upon	p97/VCP	depletion,	 in	 contrast	 to	 the	 sig-
nificantly increased number of GFP-LC3 puncta in ATXN3-depleted 
cells	(Figure	3b,c).	In	cells	that	had	been	co‐depleted	of	p97/VCP	and	
ATXN3 (Figure 3a-c), the number of GFP-LC3 puncta as well as their 
distribution pattern was similar to what was observed when ATXN3 
alone	was	depleted,	suggesting	that	ATXN3	acts	upstream	of	p97/
VCP. These observations are in line with a stimulatory role of ATXN3 
in autophagy through regulation of an event that precedes the matu-
ration	step	stimulated	by	p97/VCP.
2.4 | ATXN3 interacts directly with 
GABARAP and LC3C
In light of its promiscuous interaction with various ubiquitin-re-
lated	 proteins	 (Burnett,	 Li,	&	Pittman,	 2003;	 Ferro	 et	 al.,	 2007;	
Pfeiffer	 et	 al.,	 2017),	 we	 wondered	 whether	 ATXN3	 binds	 the	
autophagy receptors LC3 and GABARAP, which belong to the 
Atg8	family	of	ubiquitin‐like	modifiers	(Schaaf,	Keulers,	Vooijs,	&	
Rouschop,	2016).	To	this	end,	we	incubated	recombinant	ATXN3	
with LC3A and GABARAP agarose beads, which revealed a ro-
bust interaction between ATXN3 and GABARAP, while binding 
of	ATXN3	 to	 LC3A	was	 not	 observed	 (Figure	 4a).	 Similar	 to	 re-
combinant ATXN3, we found that ectopically expressed ATXN3 
with N-terminal histidine (10xHis) and C-terminal hemagglutinin 
(HA) epitope tags (10xHisATXN3HA) as well as endogenous ATXN3 
binds GABARAP. Additionally, interaction with LC3A was also de-
tected,	 albeit	much	 less	 pronounced	 (Figure	 4b).	 As	 an	 internal	
control,	we	validated	that	p62,	a	known	Atg8‐interacting	protein,	
was precipitated by the beads. The specificity of the ATXN3 sig-
nal was confirmed, as induction of 10xHisATXN3HA increased the 
amounts of ATXN3 in the GABARAP precipitates, while siRNA-
mediated depletion of ATXN3 resulted in a loss of the ATXN3 
signal	(Figure	S5).
As	there	are	six	Atg8	family	members	in	mammalian	cells,	we	next	
sought to characterize the specificity of ATXN3 for these proteins fur-
ther. Lysates of HeLa 10xHisATXN3HA	were	incubated	with	GST‐LC3A,	
GST‐LC3B,	 GST‐LC3C,	 GST‐GABARAP,	 GST‐GABARAPL1,	 or	 GST‐
GABARAPL2 immobilized on glutathione beads, and precipitates were 
analyzed for 10xHisATXN3HA. This approach confirmed that 10xHisATX-
N3HA	 precipitated	with	 GST‐GABARAP	 and	 to	 a	 lesser	 extent	with	
GST‐LC3A.	Additionally,	we	detected	strong	binding	of	GST‐LC3C	to	
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10xHisATXN3HA	(Figure	4c).	To	define	the	domain	in	ATXN3	that	is	re-
quired for GABARAP binding, we generated a series of green fluores-
cent protein (GFP)-tagged fragments of ATXN3 that were ectopically 
expressed	in	HeLa	cells	(Figure	4d).	Incubation	of	the	cell	lysates	with	
GABARAP-coated beads revealed that the N-terminal half of ATXN3, 
comprising	the	catalytic	Josephin	domain,	interacted	with	GABARAP	
(Figure	 4e).	 Further	 deconvolution	 showed	 that	 the	 interaction	 be-
tween	the	C‐terminal	part	of	the	Josephin	domain	and	GABARAP	was	
most pronounced with weaker binding of GABARAP to the N-terminal 
part	 of	 the	Josephin	 domain	 (Figure	 4e).	These	 results	 suggest	 that	
ATXN3 interacts with GABARAP, and likely LC3C, through multiple 
binding	sites	in	its	Josephin	domain.
2.5 | The Josephin domain contains two conserved 
LIR motifs
In	silico	analysis	of	the	ATXN3	sequence	(NP_004984.2),	using	iLIR	
(Kalvari	et	al.,	2014),	revealed	the	presence	of	six	putative	LIRs	([W/F/
Y]‐x‐x‐[L/V/I])	with	variable	PSSM	scores	(Figure	S6A,B).	All	putative	
LIRs	were	located	in	the	Josephin	domain,	whereas	no	candidate	LIRs	
were identified in the C-terminal part of ATXN3. To identify the LIR(s) 
responsible for the GABARAP/LC3C interaction, we synthesized and 
spotted	the	N‐terminal	sequence	of	ATXN3	(1–182),	encompassing	
the	Josephin	domain,	as	20‐mer	peptides	on	cellulose	membranes,	
and	analyzed	binding	of	GST‐tagged	fusions	of	GABARAP	and	LC3C	
to the immobilized peptides (Figure 5a,b). LC3C bound to a LIR se-
quence	located	in	the	central	part	of	the	Josephin	domain	(FFSI,	aa	
74–77,	 LIR1),	 while	 both	 GABARAP	 and	 LC3C	 bound	 to	 peptides	
containing a LIR sequence located more toward the C-terminal part 
of	the	Josephin	domain	(WFNL,	aa130‐133,	LIR2)	(Figure	5b,	Figure	
S6B).	This	observation	may	also	provide	an	explanation	for	the	ob-
served	binding	of	both	halves	of	the	Josephin	domain	to	GABARAP	
as LIR1 and LIR2 are located in the N-terminal and C-terminal frag-
ments	 of	 the	 Josephin	 domain,	 respectively.	 Both	 LIRs	 are	 highly	
conserved in ATXN3 orthologues among various species, suggest-
ing	a	conserved	function	for	these	motifs	(Figure	5c).	We	assessed	
the catalytic activity of ATXN3 mutants in which the critical resi-
dues	in	LIR1	or	LIR2	or	both	had	been	mutated	toward	K63‐linked	
hexa-ubiquitin chains in vitro and found that both mutations com-
promised	 the	deubiquitylation	activity	of	ATXN3	 (Figure	S6C).	For	
the LIR1 mutant, this result was expected as this LIR motif shares a 
critical	 residue	with	the	ubiquitin‐binding	site	1	 (UbS1;	 Ile77Glu78)	
in	 the	ATXN3	Josephin	domain.	This	site	has	recently	been	shown	
to be crucial for ATXN3 activity as it is required to position the ubiq-
uitin C-terminus for cleavage (Nicastro et al., 2010). LIR2 is located 
directly	adjacent	to	Asp134,	an	essential	residue	of	the	catalytic	triad	
of ATXN3, which may explain why mutating LIR2 renders ATXN3 in-
active.	Since	the	expression	of	an	ATXN3	LIR2	mutant	in	mammalian	
cells and protein purification from bacteria turned out to be problem-
atic with low expression and yields, we suspect that these mutations 
may also impair folding of the catalytic domain. Due to the lack of 
DUB activity of these mutants combined with the low expression 
levels, we have been unable to address the significance of these LIRs 
for the functional role of ATXN3 in autophagy.
The specific interaction of the catalytic domain of ATXN3 with 
GABARAP and LC3C raised the question whether ATXN3 displays 
protease	activity	 toward	these	ubiquitin‐like	proteins.	While	 the	au-
thentic	 protease	 of	 GABARAP,	 Atg4B	 (Tanida	 et	 al.,	 2004),	 readily	
F I G U R E  3  ATXN3	acts	upstream	of	p97/VCP	in	the	autophagy	pathway.	(a)	Knockdown	efficiencies	of	siRNA	oligos	targeting	ATXN3	
and/or	p97/VCP	after	48	hr.	(b)	Representative	micrographs	of	HOS	GFP‐LC3	cells	depleted	of	ATXN3,	p97/VCP,	or	both	using	the	indicated	
siRNAs.	Cells	were	starved	in	the	presence	of	100	nM	bafilomycin	A1	for	4	hr.	Scale	bar:	20	μm. (c) Quantification of GFP-LC3 puncta in 
(b).	Data	are	shown	as	box	plot	with	median	and	5–95	percentile	of	two	independent	experiments,	n	>	1,200,	*p	≤	.05,	**p	≤	.01,	***p	≤	.001	
(Kruskal–Wallis	test)
(a) (b) (c)
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cleaved a recombinant GABARAP-GFP fusion protein, ATXN3 did not 
display any activity toward this fusion protein (Figure 5d).
2.6 | ATXN3 localizes to autophagosomes
Based on the interactions identified above, we wondered whether 
ATXN3 localizes to autophagosomes. To this end, we analyzed 
the distribution of ATXN3 in HeLa cells under control conditions, 
when basal autophagy is active, and under nutrient starvation to 
stimulate autophagy. Epitope-tagged 10xHisATXN3HA showed a 
diffuse staining in both the cytosol and nucleus, which remained 
unchanged	during	starvation	(Figure	6a,	Figure	S7A).	Next,	we	ana-
lyzed the localization of 10xHisATXN3HA in cells that overexpressed 
3xMyc‐tagged	ATG16L1	(3xMycATG16L1)	as	this	is	known	to	induce	
the formation of pre-autophagosomal structures and stall their 
progression (Polson et al., 2010). As expected, this resulted in an 
increase	 in	WIPI2‐positive	 puncta,	 a	marker	 for	 early	 autophago-
somes (Polson et al., 2010), which co-localized with the ectopi-
cally overexpressed 3xMycATG16L1	 (Figure	 S8).	 Notably,	 ATG6L1	
overexpression resulted in the appearance of distinct ATXN3 
puncta,	 which	 typically	 localized	 in	 close	 proximity	 to	 ATG16L1	
structures	 under	 basal	 and	 starved	 conditions	 (Figure	 6b,	 Figure	
S7B).	Overexpression	of	GFP‐tagged	LC3	also	 resulted	 in	ATXN3	
re-localization to distinct puncta, where ATXN3 co-localized with 
the GFP-LC3 foci, consistent with translocation of ATXN3 to au-
tophagosomes	(Figure	6c).
F I G U R E  4   ATXN3 directly interacts with GABARAP and LC3C. (a) Purified, recombinant ATXN3 was incubated with blocked agarose 
beads (empty beads, e.b.) or recombinant GABARAP/LC3A immobilized on agarose beads. Binding was analyzed by immunoblotting. 
(b) Cell lysates from HeLa cells expressing doxycycline (dox)-inducible 10xHisATXN3HA were incubated with blocked agarose beads (e.b.) 
or recombinant GABARAP/LC3A immobilized on agarose beads. Binding of endogenous ATXN3 and 10xHisATXN3HA was analyzed by 
immunoblotting	with	the	indicated	antibodies;	*	indicates	band	corresponding	to	ATXN3	from	previous	detection.	(c)	Cell	lysates	from	HeLa	
cells expressing dox-inducible 10xHisATXN3HA	were	incubated	with	purified,	recombinant	GST‐tagged	Atg8	proteins	and	binding	analyzed	by	
immunoblotting	with	the	indicated	antibodies.	(d)	Schematic	illustration	of	GFP‐ATXN3	constructs	used	in	(e).	(e)	Cell	lysates	from	HeLa	cells	
transfected with the indicated constructs were incubated with blocked empty agarose beads (e.b.) or recombinant GABARAP immobilized 
on agarose beads. Binding was analyzed with immunoblotting using the indicated antibodies
(a)
(d) (e)
(b) (c)
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F I G U R E  5  The	ATXN3	Josephin	domain	contains	two	conserved	LIR	motifs.	(a)	Schematic	illustration	of	peptide	spot	assay	to	identify	
LIR	motifs	in	the	ATXN3	Josephin	domain.	The	N‐terminal	sequence	of	ATXN3	(1–182)	was	synthesized	as	20‐mer	peptides	and	spotted	
on	cellulose	membranes.	(b)	Binding	of	GST‐tagged	fusions	of	GABARAP	and	LC3C	to	the	spotted	ATXN3	Josephin	peptides	was	analyzed	
by immunoblotting. (c) Conservation of the identified LIR1 and LIR2 across species. (d) Catalytic activity of recombinant ATXN3 toward 
recombinant pre-GABARAP-GFP was analyzed in vitro by incubation of 250 ng pre-GABARAP-GFP with the indicated amounts of ATXN3 
for	16	hr	at	37°C.	Recombinant	His6‐Atg4B	was	used	as	control
(a)
(b)
(c) (d)
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The observation that ATXN3 localizes to autophagosomes upon 
ATG16L1	 overexpression	 suggests	 that	 ATXN3	 transiently	 inter-
acts with early autophagosomal structures but does not progress 
through the autophagic pathway. This also implies that ATXN3 is not 
targeted for lysosomal degradation unlike other LC3/GABARAP-in-
teracting	proteins,	such	as	p62	(Pankiv	et	al.,	2007).	Consistent	with	
(a)
(b)
(c)
(d)
(e)
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this notion, inhibition of autophagy by 3-methyladenine (3-MA) or 
bafilomycin A1 in nutrient-starved cells did not result in an increase 
in	 the	 steady‐state	 levels	 of	 ATXN3,	 whereas	 p62	 was	 stabilized	
(Figure	6d,e).	We	 conclude	 that	ATXN3	 is	 an	 LC3C/GABARAP‐in-
teracting protein that is recruited to autophagosomes in a transient 
fashion, where it regulates their formation and stimulates the auto-
phagic flux.
3  | DISCUSSION
In this study, we identified ATXN3 as a GABARAP/LC3C-interacting 
DUB that localizes to autophagosomes and revealed a novel regula-
tory	 function	 in	 autophagy.	 Surprisingly,	 we	 found	 that	 nematodes	
deficient	for	ATX‐3	and	CDC‐48,	which	have	an	approximate	50%	ex-
pansion of their lifespan, are hypersensitive to starvation conditions, 
resulting in reduced survival of food-deprived mutant larvae. The star-
vation	response	required	the	catalytic	activity	of	ATX‐3,	while	CDC‐48	
deletion did not decrease viability of the worms in response to nu-
trient	starvation.	Since	longevity	is	usually	associated	with	increased	
autophagy	(Leidal	et	al.,	2018),	it	is	striking	that	the	extended	lifespan	
of the cdc‐48.1; atx‐3 double mutant worms occurs at the expense 
of the ability to cope with prolonged starvation. Interestingly, atx‐3 
mutant worms do not show increased sensitivity toward proteotoxic 
insults such as high temperature, oxidative stress, or bortezomib treat-
ment	(Kuhlbrodt	et	al.,	2011;	Rodrigues	et	al.,	2007).	Thus,	the	specific	
decrease in the survival of atx‐3 mutant worms under starvation stress 
is indicative of a specialized role of ATX-3 in the fine-tuning of au-
tophagy to survive unfavorable environmental conditions.
Our results are in striking contrast to the recent observation by 
Ashkenazi and coworkers, who identified the autophagy-regulating 
factor beclin-1 as a target for ATXN3 deubiquitylating activity and 
demonstrated polyQ-mediated binding between beclin-1/ATXN3. 
Stabilization	 of	 beclin‐1	 by	 ATXN3	 was	 proposed	 to	 explain	 the	
stimulatory	role	of	ATXN3	on	LC3	lipidation	(Ashkenazi	et	al.,	2017).	
Even though our data also argue for a stimulatory role of ATXN3 in 
autophagy, within the shorter time frame of ATXN3 depletion that 
we employed in this study, neither beclin-1 levels nor LGG-1/LC3 
lipidation was reduced upon ATX-3 or ATXN3 depletion. Moreover, 
the starvation sensitivity phenotype of atx‐3 deletion worms was 
aggravated by crippling autophagy (bec‐1 or unc‐51 depletion), sug-
gesting a conserved beclin-1-independent role in autophagy and 
degradation of long-lived proteins. It is also noteworthy that C. 
elegans ATX-3 lacks the polyQ tract present in the human protein 
(Rodrigues	et	al.,	2007),	which	shows	that	ATX‐3	is	able	to	stimulate	
autophagy independent of a polyQ stretch and strongly argues in 
favor of a function different from the polyQ-dependent regulation 
of beclin-1.
ATXN3 joined the arsenal of neurodegeneration-associated 
proteins that have been found to promote various events in the 
autophagy–lysosome	pathway	(Deng	et	al.,	2017;	Wong	&	Cuervo,	
2010). The shared commitment of these proteins to autophagy 
brings up important questions about the underlying pathophysio-
logical mechanisms of these diseases, which are characterized by 
the accumulation of aggregation-prone proteins. It is plausible that 
defects in protein degradation may contribute to disease manifesta-
tion. Interestingly, genetic tempering with autophagy in mice gives 
rise to neurodegenerative disorders with the presence of ubiqui-
tin-positive protein inclusions that are hallmarks of these diseases 
(Hara	et	al.,	2006;	Komatsu	et	al.,	2006).	With	 respect	 to	ATXN3,	
the recent identification of Huntingtin, the polyQ protein responsi-
ble	for	Huntington's	disease,	as	a	substrate	adaptor	for	autophagy,	
appears to be most relevant (Rui et al., 2015). A feature that ATXN3 
shares with Huntingtin and other cargo receptors is the binding of 
both GABARAP/LC3 and ubiquitin conjugates. However, our data 
do not support a classical role of ATXN3 in substrate delivery since 
autophagy receptors typically join their substrates to the lysosomes 
and are degraded in the process. In contrast, we did not detect lyso-
somal degradation of ATXN3. Hence, the identified LIR motifs might 
be required for the recruitment of ATXN3 to autophagosomes in a 
more	 temporally	 controlled	manner.	 Such	a	mechanism	would	not	
be unprecedented since similar targeting functions of LIR motifs 
have been described for other effector proteins in the autophagy 
pathway,	including	ULK1,	ATG4B,	and	mitogen‐activated	protein	ki-
nase	15	(MAPK15)	(Alemu	et	al.,	2012;	Colecchia	et	al.,	2012;	Skytte	
Rasmussen	et	al.,	2017).
The functional significance of the two identified LIRs will require 
further exploration before definite conclusions can be drawn. Analysis 
of	the	published	structures	of	the	Josephin	domain	indicates	that	the	
LIR1 motif is partly exposed but will have to undergo a minor confor-
mational change to align properly (Mao et al., 2005; Nicastro et al., 
2005).	Due	 to	 its	proximity	 to	 the	UbS1	site	 (Nicastro	et	al.,	2010),	
occupancy of LIR1 with LC3C will likely hinder binding of ubiquitin and 
interfere with its DUB activity. The LIR2 motif, on the other hand, is 
F I G U R E  6   ATXN3 localizes at autophagosomes. (a, b) HeLa cells expressing dox-inducible 10xHisATXN3HA were transfected with empty 
vector (a) or 3xMycATG16L1	(b)	and	10xHisATXN3HA	expression	induced	for	24	hr.	Cells	were	starved	for	2	hr,	fixed,	and	immunolabeled	
using antibodies against HA-tag and Myc-tag. Line scan at site of 3xMycATG16L1	accumulation	to	visualize	the	spatial	distribution	of	the	
proteins. The percentage of 3xMycATG16L1	puncta	that	were	associated	with	ATXN3	was	quantified.	Data	are	presented	as	mean	±	SEM of 
four independent experiments. (c) HeLa cells expressing dox-inducible 10xHisATXN3HA were transfected with GFP-LC3 and 10xHisATXN3HA 
expression	induced	for	24	hr.	Cells	were	starved	for	2	hr,	fixed,	and	immunolabeled	using	antibodies	against	HA.	Line	scan	at	site	of	GFP‐
LC3 accumulation to visualize the spatial distribution of the proteins. The percentage of GFP-LC3 puncta that co-localized with ATXN3 was 
quantified. Data are presented as mean ± SEM	of	three	independent	experiments	(d)	HeLa	cells	were	treated	as	indicated	for	4	hr	and	cell	
lysates analyzed by immunoblotting using the indicated antibodies. (e) Band intensities were quantified and normalized to β-actin and to the 
respective control treatment. Data are presented as mean ± SD	of	three	independent	experiments.	*p	≤	.05,	**p	≤	.01,	***p	≤	.001	(one‐way	
ANOVA)
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buried	within	the	Josephin	domain	and	is	of	structural	importance	for	
the integrity of this domain. Exposure of the LIR2 motif to GABARAP/
LC3C	would	therefore	require	a	conformational	change	in	the	Josephin	
domain.	While	 conformational	 changes	 upon	 substrate	 engagement	
are	not	uncommon	in	DUBs	(Hu	et	al.,	2002;	Johnston,	Riddle,	Cohen,	
&	Hill,	1999),	a	quite	dramatic	structural	reorganization	of	the	catalytic	
domain would be required to surface expose this LIR motif, making it 
unlikely, though not impossible, that it contributes to the interaction 
between LC3C/GABARAP and ATXN3. The fact that binding of LC3C/
GABARAP to the LIR(s) may inhibit the catalytic activity of ATXN3, 
while at the same time the catalytic activity is required for its role in 
autophagy, is intriguing. One possibility is that there is a relay mech-
anism in play where ATXN3 is first recruited to autophagosomes by 
binding LC3C/GABARAP followed by the replacement of GABARAP/
LC3C for a ubiquitylated substrate. This model could also explain the 
transient nature of its interaction with autophagosomes. Alternatively, 
the catalytic activity of ATXN3 may be required for processing sub-
strates	other	than	ubiquitin	chains.	While	we	did	not	detect	any	activ-
ity toward an artificial GABARAP precursor, this does not yet exclude 
the possibility that ATXN3 may process conjugates of GABARAP/
LC3C	or	other	Atg8	members.
Counterintuitively, ATXN3 depletion increases the number of 
LC3 puncta without an accompanying increment in lipidated LC3. It 
is plausible that local inhibition of the formation of autophagosomes 
by ATXN3 may ensure that the available pool of lipidated LC3 is not 
diluted among an excessively large number of autophagosomes, 
which may otherwise hinder efficient autophagic clearance. This 
model would explain why ATXN3 only localizes to a subpopulation of 
ATG16L1‐positive	structures	and	why	ATXN3	is	not	degraded	in	the	
process despite its co-localization with markers for autophagosomes. 
Thus, we propose that ATXN3 may localize to a subpopulation of 
ATG16L1	structures	that	will	not	further	progress	to	the	formation	of	
autophagosomes due to the suppressive activity of ATXN3. Although 
speculative, these models provide us with a framework for further 
exploration of the molecular role of ATXN3 in autophagy. Together, 
we conclude that ATXN3 stimulates autophagy and thereby optimizes 
the cellular response to nutrient starvation and proteotoxic stress, two 
conditions that rely heavily on autophagy.
4  | E XPERIMENTAL PROCEDURES
4.1 | Starvation of worms
Worms	 were	 maintained	 at	 20°C	 on	 NGM	 plates	 seeded	 with	
Escherichia coli (OP50). Gravid adult worms were washed off 
plates	 and	 treated	 with	 alkaline	 bleach	 (7.7	 ml	 H2O + 2 ml 10% 
bleach + 0.3 ml 10 M NaOH) to isolate embryos. The isolated em-
bryos	were	hatched	 in	M9	buffer	 at	20°C	without	 food	overnight	
(ca.	10–50	eggs/μl). The arrested first-stage larvae (L1) were incu-
bated	 in	M9	 buffer,	 rotating	 at	 20°C	 for	 the	 indicated	 number	 of	
days. To monitor starvation survival as the recovery rate upon re-
feeding,	aliquots	from	each	sample	were	taken	every	1–3	days	and	
plated on 3.5 cm NGM plates seeded with E. coli (OP50) for recovery. 
After	2	days	of	recovery	at	20°C,	surviving	worms	that	had	resumed	
growth and developed past the L1 larval stage were counted and 
removed.	Plates	were	 inspected	after	an	additional	24	hr	 to	count	
worms that developed slower and were missed in the first round of 
counting. The recovery rate observed on the first day of starvation 
(24	hr	 after	 egg	 isolation	 and	 incubation	 in	M9	buffer)	was	 set	 to	
100% and recovery rates of the following days normalized to this.
4.2 | Motility assay
Worms	were	grown	on	E. coli	 (OP50)	bacteria	 at	20°C	until	 day	1	
adulthood	(72	hr	after	L1	stage).	Worms	were	transferred	to	a	drop	
of M9 buffer, and after 30 s of adaptation, the number of body bends 
of n = 20 worms was counted for 30 s. A body bend was defined as 
change in direction of the bend at the mid-body.
4.3 | Long‐lived protein degradation
Reverse	transfection	of	U2OS	cells	was	done	by	dilution	of	siRNA	
oligonucleotides and Lipofectamine 2000 in DMEM + GlutaMAX. 
Cells	were	added	at	a	density	of	8.8	×	104 cells/ml in a final volume 
of	400	μl	(final	siRNA	concentration:	40	nM).	Cells	were	labeled	by	
the addition of 0.125 μCi/ml	L‐[14C]	valine	to	the	medium	for	24	hr,	
followed	by	two	washes	and	a	16‐hr	chase	in	medium	containing	
10 mM nonradioactive l-valine, to allow degradation of short-lived 
proteins.	 Subsequently,	 cells	were	washed	 and	 subjected	 to	 the	
indicated treatments in medium containing 10 mM nonradioactive 
l‐valine	for	4	hr.	Radioactivity	in	the	acid‐soluble	and	acid‐insolu-
ble	fractions	was	measured	using	Ultima	Gold	LSC	cocktail	(Perkin	
Elmer) and a liquid scintillation counter (Tri-Carb 3100T Perkin 
Elmer).
4.4 | Peptide scan
The	N‐terminal	sequence	of	human	ATXN3	(aa	1–182;	NP_004984.2)	
was synthesized as 20-mer peptides with two amino acid offsets on 
cellulose membranes using a MultiPep automated peptide synthe-
sizer	(INTAVIS	Bioanalytical	Instruments)	as	described	(Knaevelsrud	
et	al.,	2013).	Peptide	arrays	were	blocked	in	1%	casein	in	PBS‐T	for	
1 hr at RT. Overlays were done using 1 μg/ml	GST‐fusion	proteins	or	
GST	in	1%	casein	PBS‐T	overnight	at	4°C.	Membranes	were	washed	
three	times	in	PBS‐T	and	bound	proteins	detected	by	immunoblot-
ting	with	anti‐GST‐HRP.
See	Supporting	Information	Experimental	Procedures	for	all	ad-
ditional experimental procedures.
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